BCI 1415
Alternative Names: BCI-1415Latest Information Update: 03 Jul 2024
At a glance
- Originator BCI Pharma
- Class Analgesics; Anti-inflammatories; Antineoplastics; Small molecules
- Mechanism of Action Macrophage colony-stimulating factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Inflammation; Pain